RELIEF FROM NEUROPATHIC PAIN
Relief From Neuropathic Pain
D’OXYVA® (deoxyhemoglobin vasodilator) is a novel, clinically validated blood flow and nerve stimulant for people suffering from neuropathy. In various clinical trials, D’OXYVA has validated leading independent research results and demonstrated above-average results in improving a host of physiological functions at the same time.
Subjects suffering from high blood sugar have reported neuropathy pain relief minutes after D’OXYVA was administered and long-term blood sugar level improvements in just a few weeks.
Rapid and gentle skin delivery (over-the-skin) delivery with the D’OXYVA light-weight and hand-held device has recorded improving the blood microcirculation or perfusion index (PI) by 33%* on average in all participants. (Measured lasting results at 5–60 minutes and up to 4 hours after single 5–minute D’OXYVA delivery on skin surface, no reduction in PI levels.)
TAKING D’OXYVA DAILY, USERS HAVE REPORTED A NUMBER OF QUALITY OF LIFE BENEFITS BEYOND SIGNIFICANTLY REDUCING RISKS OF CHRONIC CONDITIONS, INCLUDING BUT NOT LIMITED TO:
Relief from symptoms of microvascular complications
Significantly increased cardiac function, physical fitness, endurance and strength, muscle size, body tone, faster recovery from sports injuries and surgical trauma
Promoting and maintaining a healthy weight, improving general mobility, deeper, more restful sleep
Significant improvement of mental acuity; concentration, heightened stamina, energy, and focus while managing stress
Improved vitals across the board during checkups with zero adverse event reports after years of regular use by people with various health, demographic, and ethnic backgrounds
D’OXYVA USERS REVIEW
MEASURE / FEEL / SEE RESULTS IN 5 WEEKS**
Over two dozen clinical studies demonstrated outsized results at clinics and at home with zero adverse events. For example, D’OXYVA® (deoxyhemoglobin vasodilator) has been recording significant results also as a varicose vein solution while delivering major clinical outcomes for well over 90% of users. Average results rounded for display, based on number of enrolled subjects in each clinical study with D’OXYVA and user feedback.
Read D’OXYVA Clinical Evidence >>
Ask your doctor before taking D’OXYVA. For prescription for medical use. Read D’OXYVA Regulatory Statements >>